Morning Overview on MSN
The FDA approved a lower-dose contrast agent to cut patients’ exposure during MRI scans
Patients who need repeated MRI scans with contrast dye could soon receive a fraction of the gadolinium they currently get.
The FDA has approved Bayer’s Ambelvist (gadoquatrane), the lowest-dose macrocyclic GBCA for adult and pediatric contrast-enhanced CNS and body MRI exams.
Gadolinium-based contrast agents alone don't cause patients to develop nephrogenic systemic fibrosis
Even at very high doses, gadolinium-based contrast agents alone are not sufficient to cause nephrogenic systemic fibrosis (NSF) in patients with kidney problems, according to a study performed at the ...
NEW ORLEANS — For contrast-enhanced imaging in multiple sclerosis (MS), all gadolinium-based agents accumulate in body tissue but to greatly varying degrees. While the long-term effect of gadolinium ...
Please provide your email address to receive an email when new articles are posted on . Researchers have developed a potential alternative to gadolinium-based contrast agents for magnetic resonance ...
Adverse reactions from gadolinium-based contrast agents used during MRI rarely occur, study suggests
Acute adverse reactions from gadolinium-based contrast agents used during magnetic resonance imaging to help improve the information seen on the images rarely occur, according to a study. Acute ...
Gadolinium-based contrast agents (GBCAs) used in MRI and angiography contain a chelated form of the toxic heavy metal that was assumed to clear the body shortly after intravenous administration. [1] ...
The European Medicines Agency (EMA) on Friday said it plans to suspend the marketing authorization for three gadolinium contrast agents and restrict the use of others after a review by the agency's ...
Gadolinium-based contrast agents are integral to modern magnetic resonance imaging, enhancing diagnostic accuracy by shortening proton relaxation times and improving tissue contrast. Gadolinium(III) ...
An unexpected discovery surprised a scientist at the Max Planck Institute for Intelligent Systems in Stuttgart: Nanometer-sized diamond particles, which were intended for a completely different ...
The FDA has approved Ambelvist, a macrocyclic gadolinium-based option for contrast-enhanced MRI, now the lowest ...
A team of Massachusetts General Hospital (MGH) researchers has developed a potential alternative to gadolinium-based contrast agents (GBCAs) for magnetic resonance imaging (MRI). In their report that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results